FOXP3 and GARP (LRRC32): The master and its minion

Biology Direct

Volumn 5, Issue , 2010, Pages

  Probst Kepper, Michael ^a   Buer, Jan ^b  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; MEMBRANE PROTEIN; NEUROPILIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; MOUSE; REGULATORY T LYMPHOCYTE; SEQUENCE HOMOLOGY;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MEMBRANE PROTEINS; MICE; NEUROPILIN-1; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77249158949     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-5-8     Document Type: Note

References (48)

1. Ziegler SF. FOXP3: Of Mice and Men. Annu Rev Immunol 2006, 24:209-226. 10.1146/annurev.immunol.24.021605.090547, 16551248.
2. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003, 15:430-435. 10.1097/00002281-200307000-00010, 12819471.
3. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342. 10.1038/ni909, 12612581.
4. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341. 10.1016/j.immuni.2005.01.016, 15780990.
5. Lin W, Haribhai D, Relland L, Truong N, Carlson M, Williams C, Chatila T. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 2007, 8:359-368. 10.1038/ni1445, 17273171.
6. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061. 10.1126/science.1079490, 12522256.
7. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336. 10.1038/ni904, 12612578.
8. Ocklenburg F, Moharregh-Khiabani D, Geffers R, Janke V, Pfoertner S, Garritsen H, Groebe L, Klempnauer J, Dittmar KE, Weiss S, Buer J, Probst-Kepper M. UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Lab Invest 2006, 86:724-737. 10.1038/labinvest.3700432, 16702978.
9. Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. PNAS 2005, 102:5126-5131. 10.1073/pnas.0501701102, 556008, 15795373.
10. Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8:277-284. 10.1038/ni1437, 17220892.
11. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445:766-770. 10.1038/nature05479, 17220876.
12. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK. The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs. J Clin Invest 2005, 115:3276-3284. 10.1172/JCI24685, 1242190, 16211090.
13. Hori S. Rethinking the molecular definition of regulatory T cells. Eur J Immunol 2008, 38:928-930. 10.1002/eji.200838147, 18395863.
14. Roncarolo MG, Gregori S. Is FOXP3 a bona fide marker for human regulatory T cells?. Eur J Immunol 2008, 38:925-927. 10.1002/eji.200838168, 18395862.
15. Gavin MA, Torgerson TR, Houston E, deRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006, 103:6659-6664. 10.1073/pnas.0509484103, 1458937, 16617117.
16. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007, 19:345-354. 10.1093/intimm/dxm014, 17329235.
17. François V, Ottaviani S, Renkvist N, Stockis J, Schuler G, Thielemans K, Colau D, Marchand M, Boon T, Lucas S, Bruggen P. The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells. Cancer Res 2009, 69:4335-4345. 10.1158/0008-5472.CAN-08-3726, 19435913.
18. Wang F, Ioan-Facsinay A, Voort EIH, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007, 37:129-138. 10.1002/eji.200636435, 17154262.
19. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T cell receptor stimulation is TGF{beta}-dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990. 10.1182/blood-2007-06-094656, 2018674, 17644734.
20. Stockis J, Fink W, Francois V, Connerotte T, de Smet C, Knoops L, Bruggen P, Coulie PG, Lucas S. Comparison of stable human Treg and Th clones by transcriptional profiling. Eur J Immunol 2009, 39:869-882. 10.1002/eji.200838807, 19224638.
21. Probst-Kepper M, Geffers R, Kröger A, Viegas N, Erck C, Hecht HJ, Lünsdorf H, Roubin R, Moharregh-Khiabani D, Wagner K, Ocklenburg F, Jeron A, Garritsen H, Arstila TP, Kekäläinen E, Balling R, Hauser H, Buer J, Weiss S. GARP: a key receptor controlling FOXP3 in human regulatory T cells. Journal of Cellular and Molecular Medicine 2010, 13:3343-3357.
22. Takaki H, Ichiyama K, Koga K, Chinen T, Takaesu G, Sugiyama Y, Kato S, Yoshimura A, Kobayashi T. STAT6 Inhibits TGF-β1-mediated Foxp3 Induction through Direct Binding to the Foxp3 Promoter, Which Is Reverted by Retinoic Acid Receptor. J Biol Chem 2008, 283:14955-14962. 10.1074/jbc.M801123200, 18400747.
23. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, Melamed R, Mathis D, Benoist C. Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature. Immunity 2007, 27:786-800. 10.1016/j.immuni.2007.09.010, 18024188.
24. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. Identification of a Regulatory T cell specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression. PLoS One 2008, 3:e27705.
25. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. PNAS 2009, 106:13439-13444.
26. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM. GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009, 106:13445-13450. 10.1073/pnas.0901944106, 19651619.
27. Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur J Immunol 2009, 39:3312-3322.
28. Probst-Kepper M, Kröger A, Garritsen HSP, Buer J. Perspectives on Regulatory T Cell Therapies. Transfus Med Hemother 2009, 36:302-308.
29. Probst-Kepper M, Balling R, Buer J. FOXP3: Required but Not Sufficient. The Role of GARP (LRRC32) as a Safeguard of the Regulatory Phenotype. Curr Mol Med 2010,
30. Pfoertner S, Jeron A, Probst-Kepper M, Guzman CA, Hansen W, Westendorf AM, Toepfer T, Schrader AJ, Franzke A, Buer J, Geffers R. Signatures of Human Regulatory T Cells: An Encounter with Old Friends and New Players. Genome Biology 2006, 7:R54-1-R54-18.
31. Tran DQ, Shevach EM. Therapeutic potential of FOXP3 regulatory T cells and their interactions with dendritic cells. Hum Immunol 2009, 70:294-299. 10.1016/j.humimm.2009.02.007, 19236900.
32. Reinwald S, Wiethe C, Westendorf AM, Breloer M, Probst-Kepper M, Fleischer B, Steinkasserer A, Buer J, Hansen W. CD83 Expression in CD4+ T Cells Modulates Inflammation and Autoimmunity. J Immunol 2008, 180:5890-5897.
33. Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. Blood 2008, 110:2537-2544.
34. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, Rehli M. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 2009, 19:1165-1174. 10.1101/gr.091470.109, 2704427, 19494038.
35. Wan YY, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 2009, 28:647-659.
36. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC, Roncarolo MG. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002, 196:1335-1346. 10.1084/jem.20021139, 2193983, 12438424.
37. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W. TGF-beta1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 2004, 172:834-842.
38. Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, Shevach EM. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 2009, 113:5125-5133. 10.1182/blood-2009-01-199950, 19299332.
39. Glinka J, Prud'homme GJ. Neuropilin-1 is a receptor for transforming growth factor -1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 2008, 84:302-310. 10.1189/jlb.0208090, 2504713, 18436584.
40. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting Edge: TGF-beta Induces a Regulatory Phenotype in CD4+CD25- T Cells through Foxp3 Induction and Down-Regulation of Smad7. J Immunol 2004, 172:5149-5153.
41. Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, O'Shea JJ, Shevach EM. CD4 FoxP3 regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 2008, 205:1975-1981. 10.1084/jem.20080308, 2526184, 18710931.
42. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. Frontline: Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004, 34:623-630. 10.1002/eji.200324799, 14991591.
43. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interaction with Dendritic Cells during Antigen Recognition. Immunity 2008, 28:402-413. 10.1016/j.immuni.2008.01.012, 2726439, 18328743.
44. Geretti E, Klagsbrun M. Neuropilins: Novel Targets for Anti-Angiogenesis Therapies. Cell Adh Migr 2007, 1:56-61. 2633972, 19329879.
45. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis P, Dudbridge F, Zwaginga JJ, Watkins NA, Schoot CE, Ouwehand WH. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 2007, 109:3260-3269. 10.1182/blood-2006-07-036269, 17192395.
46. O'Connor N, Salles I, Cvejic A, Watkins NA, Walker A, Garner S, Macaulay IC, Steward M, Zwaginga J, Bray S, Dudbridge F, de Bono B, Goodall AH, Deckmyn H, Stemple DL, Ouwehand WH, . Bloodomics Consortium Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood 2008, 113:4754-4762. 10.1182/blood-2008-06-162693, 2680375, 19109564, Bloodomics Consortium.
47. Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP. Foxp3 Regulates Megakaryopoiesis and Platelet Function. Arterioscler Thromb Vasc Biol 2009, 29:1874-1882. 10.1161/ATVBAHA.109.193805, 19661482.
48. Cai H, Reed RR. Cloning and Characterization of Neuropilin-1-Interacting Protein: A PSD-95/Dlg/ZO-1 Domain-Containing Protein That Interacts with the Cytoplasmic Domain of Neuropilin-1. J Neurosci 1999, 19:6519-6527.